Fundz

Entera Bio Ltd reported raising $6.61 Million in an initial SEC Form D filing, from an offering of $6.61 Million

PUBLIC · ENTXJan 02, 2024

Amount Raised

$6.61 Million

$6.61 Million sold, per SEC Form D (first sale Dec 20, 2023)

Round Type

Venture

IsraelBiotechnologyHealthcare

Quick answer

Entera Bio Ltd raised $6.61 Million in a funding round, dated December 20, 2023. Entera Bio Ltd is based in Israel.

How much did Entera Bio Ltd raise?
Entera Bio Ltd raised $6.61 Million in a funding round on December 20, 2023.
What does Entera Bio Ltd do?
Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics.
Where is Entera Bio Ltd based and how big is it?
Entera Bio Ltd is based in Israel. Fundz records about 22 employees.
Who are the decision-makers at Entera Bio Ltd?
Fundz holds 2 contacts at Entera Bio Ltd, including the CFO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Entera Bio Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Vektor Medical raised $29M on February 2, 2024.
  • SPR Therapeutics raised $85M (Funding Round) on February 2, 2024.
  • Pharmazz raised $150K (Seed) on February 2, 2024.
  • Skye Bioscience raised $50M on January 31, 2024.
  • SPR Therapeutics raised $26M on January 30, 2024.
  • Aspira Women’s Health raised $6.5M on January 26, 2024.

Who to call at Entera Bio Ltd, and when

A new round usually means Entera Bio Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Entera Bio Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Entera Bio Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Entera Bio Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Entera Bio Ltd

Location

KIRYAT HADASSAH, MINRAV BUILDING

Israel

About

Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract. Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. Entera’s Proprietary Technologies Act Synergistically to Transport and Protect Large Molecules.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Entera Bio Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDana, CFO hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Entera Bio Ltd's next move

See what Strategic adds

Entera Bio Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.